Related Experiment Videos

[The molecular pathology of RET protooncogene in families with multiple endocrine neoplasia type 2A]

J Biarnés1, M Miranda, J Corral

  • 1Departamento de Genética Molecular, L'Hospitalet de Liobregat, Barcelona.

Medicina Clinica
|September 21, 1996
PubMed
Abstract

Insights

Multiple endocrine neoplasia type 2A (MEN 2A) is linked to RET proto-oncogene mutations at codon 634. Identifying these specific RET mutations enables early diagnosis and presymptomatic screening for MEN 2A.

Area of Science:

  • Genetics
  • Oncology
  • Endocrinology

Background:

  • Multiple endocrine neoplasia type 2A (MEN 2A) is an inherited disorder.
  • MEN 2A is characterized by medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
  • RET proto-oncogene mutations are implicated in MEN 2A, often involving codon 634.

Purpose of the Study:

  • To investigate the specific mutations within codon 634 of the RET proto-oncogene in MEN 2A patients.
  • To characterize the genetic basis of MEN 2A in affected families.

Main Methods:

  • Studied 65 unrelated MEN 2A patients from seven families.
  • Employed polymerase chain reaction, segregation analysis, sequence analysis, and restriction enzyme digestion.

Main Results:

  • All investigated mutations were located in codon 634 of the RET gene.
  • Identified specific base pair substitutions: TGC to TAC (4 families), TGC to TGG (2 families), and TGC to CGC (1 family).

Conclusions:

  • Confirmed that all MEN 2A mutations in this cohort occurred at codon 634 of the RET gene.
  • Characterization of these mutations facilitates early and presymptomatic diagnosis of MEN 2A.

Related Concept Videos